Comparison of the efficacy of 308nm excimer lamp v/s smashed skin grafting with 308nm excimer lamp in the treatment of vitiligo: A randomised control trial.

S Nijalingappa Medical College and H S K Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Patient willing to give informed consent.
•2.Patients with stable vitiligo. Stable vitiligo is deï¬?ned as a patient reporting the absence of new lesions, absence of the progression of existing lesions and absence of Koebner phenomenon in the previous year.
•3.Patients with age >15 years and <60years.
•4.Patients refractory to topical and systemic treatment.
•5.Patients not on any treatment 3 months prior to start of study.

•1.Patient with vitiligo involving >20% body surface area involvement.
•2.Patients with bleeding and clotting disorders.
•3.Pregnant females.
•4.Patients with systemic disorders.
•5.Patients having tendency for keloid formation.
•6.Patients with reactive serology (HIV, HBsAG and VDRL).
•7.Patients with history of photodermatosis or history of skin cancer.
•8.Patients not willing for the procedure and not willing for regular follow up.
•9.Patients with unrealistic expectations.

发起方

S Nijalingappa Medical College and H S K Hospital